![]() |
|
|
NR Campbell, JA Van Loon, RS Sundaram, MM Ames, C Hansch and R Weinshilboum
Department of Pharmacology, Mayo Clinic, Rochester, Minnesota 55905.
Phenol sulfotransferase (PST) catalyzes the sulfate conjugation of many phenolic drugs. Human liver contains thermostable (TS) and thermolabile forms of PST. Ion exchange chromatography shows that two isozymes of TS PST (peaks I and II) are present in human liver preparations. Rat liver contains four forms of PST that can be separated by ion exchange chromatography. Quantitative structure-activity relationship (QSAR) analysis was used to study phenolic substrates for both human and rat liver PST. Thirty-six substituted phenols were tested as substrates for partially purified human liver TS PST peak I. QSAR analysis resulted in derivation of the following equation: log 1/Km = 0.92 (+/- 0.18)log P - 1.48 (+/- 0.38)MR'4 - 0.64 (+/- 0.41)MR3 + 1.04 (+/- 0.63)MR2 + 0.67(+/- 0.44) sigma- + 4.03 (+/- 0.42). In this equation Km is the Michaelis constant, P is the octanol-water partition coefficient, MR is the molar refractivity of substituents at the 2-, 3-, and 4-positions, and sigma- is the Hammett constant. Values of log 1/Km calculated with this equation were highly correlated with log 1/Km values (r = 0.950) that were observed experimentally. Nine phenols were also tested as substrates for partially purified human liver TS PST peak II. Log 1/Km values for these compounds were significantly correlated for the two isozymes of TS PST (r = 0.992, p less than 0.001). QSAR analysis was also used to derive equations that described the behavior of phenolic substrates for rat liver PST forms I and II. These equations differed substantially from the equation derived for compounds tested with human liver TS PST peak I. Therefore, the characteristics of the active sites of human liver TS PST peak I and rat liver PST forms I and II appear to differ. Application of these equations may make it possible to predict Km values of phenolic substrates for human liver TS PST and for rat liver PST forms I and II.
This article has been cited by other articles:
![]() |
G. R. Tulik, S. Chodavarapu, R. Edgar, L. Giannunzio, A. Langland, B. Schultz, and J. D. Beckmann Inhibition of Bovine Phenol Sulfotransferase (bSULT1A1) by CoA Thioesters. EVIDENCE FOR POSITIVE COOPERATIVITY AND INHIBITION BY INTERACTION WITH BOTH THE NUCLEOTIDE AND PHENOL BINDING SITES J. Biol. Chem., October 11, 2002; 277(42): 39296 - 39303. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Vaidyanathan and T. Walle Glucuronidation and Sulfation of the Tea Flavonoid (-)-Epicatechin by the Human and Rat Enzymes Drug Metab. Dispos., August 1, 2002; 30(8): 897 - 903. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-H. Xu, T. C. Wood, A. A. Adjei, and R. M. Weinshilboum Human 3'-Phosphoadenosine 5'-Phosphosulfate Synthetase: Radiochemical Enzymatic Assay, Biochemical Properties, and Hepatic Variation Drug Metab. Dispos., February 1, 2001; 29(2): 172 - 178. [Abstract] [Full Text] |
||||
![]() |
R. Dajani, A. Cleasby, M. Neu, A. J. Wonacott, H. Jhoti, A. M. Hood, S. Modi, A. Hersey, J. Taskinen, R. M. Cooke, et al. X-ray Crystal Structure of Human Dopamine Sulfotransferase, SULT1A3. MOLECULAR MODELING AND QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP ANALYSIS DEMONSTRATE A MOLECULAR BASIS FOR SULFOTRANSFERASE SUBSTRATE SPECIFICITY J. Biol. Chem., December 31, 1999; 274(53): 37862 - 37868. [Abstract] [Full Text] [PDF] |
||||